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Autism spectrumdisorder (ASD) is a disorder of brain
development. Most cases lack a clear etiology or
genetic basis, and the difficulty of re-enacting human
brain development has precluded understanding
of ASD pathophysiology. Here we use three-dimen-
sional neural cultures (organoids) derived from
induced pluripotent stem cells (iPSCs) to investigate
neurodevelopmental alterations in individuals with
severe idiopathic ASD. While no known underlying
genomic mutation could be identified, transcriptome
and gene network analyses revealed upregulation
of genes involved in cell proliferation, neuronal dif-
ferentiation, and synaptic assembly. ASD-derived
organoids exhibit an accelerated cell cycle and over-
production of GABAergic inhibitory neurons. Using
RNA interference, we show that overexpression
of the transcription factor FOXG1 is responsible for
the overproduction of GABAergic neurons. Altered
expression of gene network modules and FOXG1
are positively correlated with symptom severity.
Our data suggest that a shift toward GABAergic
neuron fate caused by FOXG1 is a developmental
precursor of ASD.INTRODUCTION
Rare penetrant mutations, common genetic variants, and envi-
ronmental factors are known to contribute risk to ASD, yet, about
80% of the cases have no clear etiology and no pathogenetic
model. A large number of rare mutations have been identified
in the context of syndromic and non-syndromic ASD and havebeen modeled in various organisms. However, these mutations
are extremely heterogeneous, each accounting for less than
1%–2% of cases. Furthermore, in no instance have they been
shown to be sufficient to cause ASD; rather, they interact with
other inherited and non-inherited risk factors. Some mutations
involve synapse-associated molecules (Su¨dhof, 2008; Zoghbi
and Bear, 2012) and have led to the widespread notion that alter-
ations in the assembly of synaptic connections are key in the
pathophysiology of ASD. Others have formulated the hypothesis
that there is an excitatory/inhibitory neuron imbalance in the dis-
order (Casanova et al., 2003; Rubenstein, 2010).
The applicability of these pathogenetic mechanisms to the
great majority of ASD cases remains unknown. Furthermore,
the heterogeneity of phenotypes found when modeling these
mutations in animals and the inherent difficulty in creating
behavioral phenotypes of ASD in rodents have complicated the
construction of credible animal models of ASD. It is possible
that the heterogeneity of rare mutations found in ASD, as
currently conceptualized, denies a unified understanding of the
pathophysiology of the disorder. However, emerging evidence
suggests that current genomic data, when considered in the
framework of gene network analyses, point to a common patho-
physiological substrate in ASD rooted in the embryonic develop-
ment of the cerebral cortex (Parikshak et al., 2013; Willsey et al.,
2013).
Here, we have taken the approach of directly modeling
early cortical development in probands with idiopathic ASD.
We focused on individuals with increased head/brain size (mac-
rocephaly), as this is one of themost consistently replicated ASD
phenotypes (Courchesne et al., 2001) and confers poorer clinical
outcomes among ASD patients (Chaste et al., 2013; Chawarska
et al., 2011; Lainhart et al., 2006). Using induced pluripotent stem
cells (iPSCs) obtained from affected families, we have pro-
duced telencephalic organoids that recapitulate transcriptional
programs present in mid-fetal human cortical development.
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identified unexpected differences in cell-cycle time and synaptic
growth, as well as an imbalance in GABA/glutamate neuronal dif-
ferentiation in patients as compared to their unaffected family
members.
RESULTS
Genomic Analysis of iPSC Derived from Patients with
Idiopathic ASD
To analyze neurodevelopmental aspects of idiopathic ASD, we
generated iPSC lines from members of four families that each
included an ASD proband with increased head circumference
(HC) and one to three unaffected, first-degree family members
(see Figure S1A for family structure and Table S1 for data collec-
tion and participants details).
Whole-genome sequencing data were obtained on all fibro-
blasts and iPSCs for members of all families in this study. Data
were analyzed with CNVnator (Abyzov et al., 2011) for copy-
number variation (CNV) discovery and with a GATK-based
pipeline for single nucleotide variation (SNV) discovery (see Sup-
plemental Experimental Procedures). For three families with both
parents participating in the study (03, 07, and 1123), we pre-
dicted de novo CNVs and SNVs. Of the putative de novo
CNVs, only one 4.8 kb deletion (chr14:39987476-39992327)
found in the 1123 proband could be validated by qPCR. For
this event, qPCR validation showed roughly 30% copy-number
decrease in the proband relative to either of the parent, suggest-
ing that the deletion is possibly a somatic mosaic variant. This
deletion did not overlap any known genes. Proband 07-03
carries a previously uncharacterized deletion involving exon 2
in the PTEN gene (chr10:89,641,498-89,658,394), which was
also found in his unaffected father. Proband 1120 and 03 did
not carry any deleterious CNVs that could potentially be patho-
genic. On average, each proband had 112,000 rare SNVs not
previously detected by the 1000 Genomes Project. This is also
likely to include most of de novo SNVs. By intersecting rare
SNVs in probands with lists of genes whose disruption has
been previously linked to ASD (Willsey et al., 2013) as well asFigure 1. ASD Organoids Display Normal Neuronal Differentiation Pote
(A) Both control-derived and ASD-derived organoids expressmarkers for prolifera
have apico-basal polarity with N-CADHERIN+ apical end feet of radial glial cells
(B) Stereological quantification of SOX2+ proliferating radial glia progenitors a
Scale bars, 10 mm or 20 mm as indicated.
(C) Action potentials elicited by depolarizing current injections in iPSC-derived ne
indicate a membrane potential of 0 mV.
(D) Examples of spontaneous excitatory post-synaptic currents (EPSCs) recorde
maintained in vitro for 52 days.
(E) average EPSC obtained from 30 spontaneous events. The decay of the curre
(F) Histogram of the amplitude of spontaneous inward EPSCs recorded from th
neuron was 0.81 per second.
(G–I) Transcriptome correlation between organoids at terminal differentiation day
S1) and post-mortem human brain samples from the BRAINSPAN project (n = 52
region of the BrainSpan post-mortem brain samples. The y axis is the number
based on the maximum correlation coefficient and on the 95% confidence inter
AMY, amygdala; CBC, cerebellar cortex; DFC, dorsolateral frontal cortex; HIP, hi
OFC, orbital frontal cortex; STC, superior temporal cortex; STR, striatum. In (I) x
weremerged into a single ‘‘larger’’ region): NCX (i.e., FC, PC, TC, OC), neocortex;
forebrain; URL (i.e., CBC, CB, URL), upper rhombic lip.
See also Figure S3.the SFARI syndromic genes dataset (https://gene.sfari.org/
autdb/Welcome.do), we found no rare SNVs that cause a known
deleterious loss of function of an ASD gene. In summary, we
found no de novo CNVs and/or no rare SNVs in probands that
cause a known deleterious loss of function in the protein coding
sequence of a gene previously involved in rare cases of syn-
dromic or non-syndromic ASD.
Patient iPSC-Derived Telencephalic Organoids Show
Grossly Normal Organization and Neuronal Excitability
For the four families, we differentiated two to three iPSC lines per
person into organoids using a modification of our free-floating
tridimensional (3D) culture method (Mariani et al., 2012) (see
schematic outline in Figure S3A). Similarly to our previously pub-
lished preparation (Abyzov et al., 2012; Mariani et al., 2012) and
to other protocols described in the literature (Eiraku et al., 2008;
Lancaster et al., 2013) we obtained organoids characterized by
autonomously organized layers of radial glia, intermediate pro-
genitors, and neurons (Figure 1; Figures S3C and S3D).
After 11 days of terminal differentiation (TD11), the organoids
were composed of polarized, proliferating progenitors express-
ing the radial glial cell markers BLBP, NESTIN, PAX6, BRN2,
and SOX1/2. The radial glial cells underwent mitoses on the api-
cal (luminal) side, whereas neuronal precursor cells expressing
the immature neuronal proteins DCX and TUBB3, and more
mature NeuN+ neurons after 31 days of terminal differentiation
(TD31), accumulated on the basal side of the layer of radial glial
cells (Figure 1A; Figures S3C and S3D). Both ASD-derived and
unaffected family member-derived iPSCs had an equivalent po-
tential to generate neuronal cells (Figures 1A and 1B; Figures
S3C and S3D). We observed no significant change in either
perimeter or area of the organoids between control and affected
groups, except for a transient increase in ASD-derived organoid
size at day 11 (Figure S3B). This is most likely due to intrinsic fac-
tors, since the starting number of iPS cells seeded per aggregate
was the same in all experiments and the size of EBs at the begin-
ning of the differentiation was not different between patients and
controls (see Supplemental Experimental Procedures).ntial
ting neural progenitors (SOX2) and the neuronal markers TUBB3. The organoids
and pH 3+ cells undergoing mitosis at the apical side of the neuroepithelium.
nd TUBB3+ neuronal cells at TD31. Data are presented as means ± SEM.
urons from a patient and the corresponding parental control. The dashed lines
d at a holding potential of 70 mV in a neuron from a parental control that was
nt was fitted with a single exponential that gave a time constant of 1.85 ms.
e same neuron (604 events). The overall frequency of events detected in this
0 (d0) (rosette stage), day 11 and 31 (d11 and d31) (n = 45 samples, see Table
4 samples). The x axis shows the post-conceptional age in weeks or the brain
of times each iPSC-derived neuron sample was classified. Classification was
val of the maximum correlation (see Supplemental Experimental Procedures).
ppocampus; ITC, inferolateral temporal cortex; MFC, medial prefrontal cortex;
axis shows BRAINSPAN agglomerated brain regions (i.e., more brain regions
HIP, hippocampus; AMY, amygdala; VF (i.e., VF, MGE, LGE, CGE, STR), ventral
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Figure 2. WGCNA Network in Neuronal Cells from ASD Patients and Unaffected Family Controls and Correlation with Clinical Phenotypes
(A) Relationship between the modules’ eigengenes with diagnosis and time in culture. TD11: 11 days of terminal differentiation; TD31: 31 days of terminal
differentiation; F: fathers; P: probands.
(B) Module-to-module relationship by hierarchical clustering.
(C–F) Top 200 hub genes networks for three representative modules (C). Circles: genes; diamonds: genes overlapping with genes in the SFARI database
classified as associated to ASD; red: genes overexpressed at either TD11 or TD31; gray: no changes in gene expression; larger font: genes differentially
(legend continued on next page)
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To compare the electrical excitability of iPSC-derived neu-
rons from probands with those from familial controls, we
made whole-cell patch-clamp recordings from neurons in
dissociated cultures or at the edge of organoids. All neurons
examined (n = 99) expressed voltage-activated sodium and po-
tassium currents that were of similar amplitude in control and
proband neurons from two different families (Figures S3E–
S3G). Because we observed that iPSCs differentiated using
dissociated monolayers were not able to robustly generate
ventral telencephalic neurons and express virtually no GAD1+
cells, we limited our experiments to organoid preparations. In
recordings from neurons in the organoids, the voltage-activated
currents supported action potential firing in 18/18 control neu-
rons and 12/14 proband neurons, with thresholds of 42.5 ±
0.8 mV and 37.9 ± 2.1 mV (controls, probands; p = 0.06)
and action potential overshoots of 30 to 65 mV. Most neurons
fired only a single action potential, but some fired multiple
spikes (Figure 1C). In total, the electrophysiological data indi-
cate that the cells studied here display voltage-gated channels
similar to those in central neurons. In addition to these signa-
tures of electrical excitability, we also recorded spontaneous
synaptic currents in some neurons (Figures 1D–1F). In three
control neurons (of 20 tested), the fast rise (0.5–0.7 ms) and
decay (1.8–2.4 ms) of these currents and their reversal near
0 mV strongly suggested that they were AMPA-receptor EPSCs
(Figures 1D–1F). In three other neurons (2 of 17 from patients,
1 additional control), we saw occasional synaptic currents
that were larger (40 to 325 pA, at 70 mV) and which decayed
with time constants of 7 to 10 ms. Although the percentage of
neurons showing synaptic currents was low, the results clearly
demonstrate that neurons in the organoids form functional syn-
aptic connections.
Transcriptome Analysis of Organoids Derived from ASD
Individuals
To assess both the region specificity and maturity of our orga-
noid preparation in a comprehensive fashion, we analyzed the
global transcriptome of organoids by RNA-seq at each of three
time points (rosette stage, TD11, and TD31, two to three iPSC
lines per individual, total 45 samples). The organoid’s transcrip-
tomes were compared with BrainSpan, the largest dataset of
post-mortem human brain transcriptomes from embryonic age
to adulthood (Kang et al., 2011). This comparison indicated
that our preparation best reflected the transcriptome of the
human brain during early fetal human development (9 weeks
post-conception), with TD31 cells displaying significant corre-
lations also with second trimester human brain samples, up to
13–16 weeks post-conception (Figure 1G). With regards to
regional specification, the transcriptome of iPSC-derived orga-
noids was most similar to the human dorsal telencephalon
(cerebral cortex and hippocampus), particularly to dorsolateral,
medial, and orbitofrontal cortical areas, with smaller but signifi-expressed at both TD11 and TD31; (D) Pearson’s correlation betweenmodules’ ei
and TD31; *nominal p value < 0.1; (E and F) Pearson’s correlation between HC Z s
fathers (E) and the affected probands (F) at TD31.
See also Figure S4.cant homology to the cerebellar anlage and the amygdala (Fig-
ures 1H and 1I).
Next, we compared the transcriptomes of the four probands to
those of the unaffected familymembers (two to three iPSCclones
per person) at two time points, TD11 and TD31. Differential gene
expression (DGE) between the probands and the respective
fathers, used as sex-matched normal controls, identified 1,062
differentially expressed genes (DEGs) at TD11 and 2,203 DEGs
at TD31 (Table S2A), hinting at a possibly divergent develop-
mental trajectory between controls and probands. Validation by
qPCR of a subset of the DEGs identified by RNA-seq revealed
a 0.98 correlation coefficient between log2 fold changes from
the two techniques and 100% concordance in direction of
change (Table S2B). The individual-to-individual (biological) vari-
ability, as modeled in RNA-seq DGE analyses, is clearly narrow
(Table S2). The iPSC line-to-line variability is also quite low, as
shown by the boxplots of correlation coefficients within each in-
dividual (intra) and across individuals (inter) (Figure S4). In fact,
the variability between lines from the same individual is lower
than the variability between lines across individuals (Figures
S4A–S4C). This reproducibility is likely due to the robustness of
our telencephalic organoid preparation, which selects for fore-
brain progenitors while allowing spontaneous 3-D organization.
We then asked whether, at a system level, the DEGs underline
coherent alterations in groups of co-expressed genes. Using
weighted gene co-expression network analysis, WGCNA (Lang-
felder and Horvath, 2008), we identified 24 modules of co-
expressed genes across probands and controls at TD11 and
TD31, all of which survived permutation analysis (Table S3).
We estimated the modules’ eigengenes (i.e., the first principal
component of the module’s genes expression profiles) and as-
sessed their changes over time and across diagnosis (see Fig-
ure 2A). The yellow and green modules (annotated by ‘‘vascular
development’’ and ‘‘lipid metabolism’’ gene ontology [GO] cate-
gories, respectively) were enriched in downregulated DEGs (Ta-
ble S4), and their eigengenes were consistently downregulated
across time points (Figure 2A). The blue and magenta modules
(annotated by ‘‘neuronal differentiation’’ and ‘‘regulation of tran-
scription’’ GO terms, respectively) were enriched in upregulated
genes at both TD11 and TD31 (Table S4), and their eigengenes
were consistently upregulated across time points, in keeping
with their developmental annotation. The brown and tanmodules
(annotated by ‘‘synaptic transmission’’ and ‘‘gated channel
activity’’ GO terms, respectively), however, were enriched in up-
regulated genes only at TD31 (Table S4), and consistently, their
eigengenes were upregulated more at TD31 than at TD11, in
line with their synaptic functional annotation (Figure 2A). Hierar-
chical clustering of module eigengenes also showed a tighter
correlation among the green and yellow, the blue and magenta,
and the brown and tan modules (Figure 2B), suggesting
similar functions and/or tighter regulatory interactions. In sum,
probands were characterized on the transcriptome level by agengenes with log transformed HC Z scores and ADOS severity scores at TD11
cores and modules’ eigengenes or FOXG1 expression levels for the unaffected
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Figure 3. Decreased Cell-Cycle Length and Increased Neuronal/Synaptic Differentiation in ASD Probands
(A and B) Cell-cycle time determined by the formula Tc = Ts/ (%BrdU/Ki67), where Tc = cell-cycle time and Ts = S phase time. (A) Representative image of double
immunostaining for BrdU (red) and Ki67 (green) of undifferentiated iPSCs from a control individual and (B) early neuronal progenitors in monolayer cultures at
(legend continued on next page)
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downregulation of non-neuronal and a corresponding upregula-
tion of neuronal transcript modules.
We further refined our understanding of the functional an-
notations of the upregulated magenta, blue, brown, and tan
‘‘neuronal’’ modules by investigating their canonical pathways
annotations. The magenta module was significantly enriched in
transcription- and cell-cycle-related canonical pathways (Tables
S5 and S6). Indeed, among the significantly upregulated genes in
this module are a number of transcription factors (TFs) crucial for
acquisition of neural cell fates and precursor cell proliferation
in the telencephalon, including DLX6-AS1, FOXG1, EOMES,
POU3F3/BRN1, SOX3, SOX5, GSX2, ETV1, DLX1, DLX6, E2F2,
and SYNE2 (Tables S4, S5, and S6). Many of these TFs are
also hub genes (Figure 2C; Table S7). Overall, genes in the
magenta module function in the transcriptional regulation of
cell fate and cell proliferation in the forebrain.
For the blue ‘‘neuronal differentiation’’ module, canonical
pathway annotation was enriched in axon guidance and generic
transcription pathways (Tables S5 and S6). The axon guidance
genes, all upregulated in probands, included members of
the neural cell adhesion family (NCAM1, NRCAM, L1CAM, and
NFASC), semaphorin (PLXNC1 and PLXNB3), netrin (DCC
and UNC5A), Rho GTPases (PAK3 and PAK7), CDK5R1/P35,
and DCX. Many of these molecules were among the top 100
hub genes, i.e., CDK5R1, DPYSL5, DCX, DPF1, and APC2 (Fig-
ure 2C; Table S7). Hence, genes in the bluemodule are involved
in cytoskeletal regulation of various cellular functions, including
neurite outgrowth, axon guidance, cell proliferation, migration,
and survival.
For the brown and the tanmodules, the GO and top pathways
annotation were mostly related to synaptic functions, ion chan-
nels, and ligand-receptor interactions (Tables S5 and S6), which
is in harmony with their more significant eigengene upregulation
in probands at the later time point (Figure 2A). The brownmodule
displayed the strongest enrichment with respect to the SFARI
autism gene dataset, a collection of genetic information that
includes data from linkage and association studies, cytogenetic
abnormalities, and specific mutations associated with ASD
(https://gene.sfari.org) (SFARI category S to 4) (Abrahams
et al., 2013) (p value = 6.51E-5). Among the top 100 hub genes
of the brown module, 64 were upregulated at TD31, including
molecules involved in synaptic assembly, ion transport, and
post-synaptic signaling (i.e., NRXN1, NRXN2, SLITRK1,
CAMK2B, CAMK1D, NRSN1, SYT13, GRIN1, and SCN2A) (Table
S7). Among the hub genes, NRXN1, SCN2A, and TSPAN7 were
significantly upregulated as well as overlapping with genes in the
SFARI autism database (Figure 2C). The tanmodule was charac-
terized by an upregulation at TD31 of transcripts for severalTD11. *p < 0.05, ANOVAwith family as covariant. To preparemonolayer cultures fo
cultured in adhesion as monolayers until TD11.
(C and D) Representative images (C) and stereological quantification (D) of the
ASD-derived organoids at TD31.
(E–J) Increased neuronal maturation and synaptic formation in ASD-derived neuro
labeled with MAP2 and SynI (E), or MAP2 and VGAT (H), and relative quantificatio
and number of VGLUT1+ puncta (J).
The data in (A, B, D, F, G, I, and J) are presented asmeans ± SEM; **p < 0.01, ***p <
(C), 5 mm (E) and (H).potassium channels and for key components of GABAergic
neurons, including the GABA synthetic enzyme GAD1 and three
GABA receptor subunits, most of which were in the tanmodule’s
100 hub genes (Table S7).
Altered Neural Proliferation and Differentiation in
Organoids from ASD Patients
In summary, the signatures that emerged from our transcriptome
analyses as significantly perturbed in probands were tran-
scriptional regulation of cell proliferation/cell fate, neuronal
differentiation/process outgrowth, and synaptic transmission.
To functionally validate these signatures, we performedmorpho-
metric cellular analyses and immunostaining for cell fate
markers. We first studied the dynamics of the cell cycle in undif-
ferentiated iPSCs and neuronal progenitors (TD11) by BrdU
incorporation (Figures 3A and 3B). These experiments revealed
a significant decrease in cell-cycle length in ASD-derived iPSCs
(Figure 3A). We saw a similarly strong trend in early neuronal pro-
genitors cultured as monolayers (Figure 3B). However, when we
estimated the proportion of proliferating cells in more mature or-
ganoids (TD31), there was no significant difference in prolifera-
tion between ASD- and control-derived organoids (Figures 3C
and 3D). Taken together, these results suggest that a decrease
in cell-cycle length could be an early event that is present at
the iPSC undifferentiated stage and during the early stages of
neuronal differentiation, which is consistent with the transient
increase in organoid size at TD11 (Figure S3B).
We then assessed neuronal maturation and synaptic forma-
tion in organoids at TD31. Quantification of microtubule-associ-
ated protein 2 (MAP2) showed a significant increase in its density
in ASD-derived neurons (Figures 3E and 3F). Moreover, synapse
number quantification revealed a significant increase in Synap-
sin I-immunoreactive (SynI)+ puncta in ASD-derived neurons,
suggesting increased neuronal maturation and synaptic over-
growth (Figures 3E and 3G). This is in agreement with the upre-
gulated expression of the blue and brown modules (Figure 2A),
whose signatures suggested accelerated or increased neuronal
differentiation and synaptic connections in probands. Further-
more, quantification of the inhibitory VGAT (vesicular GABA
transporter) and excitatory VGLUT1 (vesicular glutamate trans-
poter-1) immunoreactivity revealed a significant increase in
VGAT-immunoreactive puncta (Figures 3H and 3I) and no signif-
icant changes in VGLUT1 puncta (Figure 3J), suggesting an in-
crease in the number of inhibitory synapses in ASD-derived
neurons.
Next, we directly tested whether there was any bias for differ-
entiation into specific neuronal subtypes. In this analysis, we
used as markers TFs which control fate choice, cell proliferation,r neuronal progenitors the neural rosettes were dissociated into single cells and
proportion of proliferating Ki67+ neuronal progenitor cells in both control and
ns (TD 31). Representative images of controls and probands organoids at TD 31
n of MAP2 density (F), number of SynI+ puncta (G), number of VGAT+ puncta (I),
0.001; t test analysis. Scale bars, 10 mm (A), 10–20 mm (B), as indicated, 10 mm
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Figure 4. ASD Organoids Show Imbalance between Glutamatergic and GABAergic Neuron Fate
(A–J) Representative images of control-derived and ASD proband-derived organoids: (A–C) Immunostaining of SOX1+ and PAX6+ proliferating radial glia
progenitors, cortical excitatory TBR2+ intermediate progenitors, and more mature TBR1+ and CTIP2+ excitatory neurons at TD31. (G–I) Immunostaining of
GABAergic inhibitory progenitor cells (DLX1-2+) and mature GABAergic interneurons (GAD1+) at TD11 and TD31. (D, E, F, and J) Box plots showing the
stereological quantification of the immunostaining. The upper and lower error bars in each box plot represent the top whisker (maximum value-quartile3) and
bottom whisker (quartile1-minimum value), respectively.
(K) Plots showing percentages of inhibitory (GAD1+) and excitatory (TBR1+, CITIP2+) neurons in ASD-derived and control-derived organoids at TD31. Total cells
are estimated by counting DAPI+ nuclei.
C = Controls, p = Probands. **p < 0.01, ***p < 0.001, t test analysis. Scale bars, 10 mm (A), (C), (E), (G), and (K), 20 mm (I) and (J). See also Figure S4 and Figure S5.and neuronal differentiation during normal telencephalic devel-
opment, many of which were members of the magenta and
blue modules (Figure 2C; Tables S5 and S6). We found that the
proportions of cortical excitatory neuron precursors of the sub-
ventricular zone expressing EOMES/TBR2, of layer 6 neurons
expressing TBR1, and of early-born layer 5 CTIP2 neurons
(also known as BCL11B) were not significantly different in ASD
and control organoids at TD31 (Figures 4A–4F), although some
of these cortical excitatory neuron markers (such as TBR1,
TBR2, CTIP2 and SOX5) were upregulated in proband-derived
organoids at the mRNA level.382 Cell 162, 375–390, July 16, 2015 ª2015 Elsevier Inc.We next investigated determinants of GABAergic inhibitory
neuronal fates using DLX1-2 (two TFs which are among the
earliest determinants of GABAergic fate in telencephalic precur-
sors cells and upregulated members of the magenta module)
and GAD1/GAD67 (the GABA synthetic enzyme, an upregulated
member of the tanmodule). The expression of these GABAergic
markers was increased significantly in organoids derived from
ASD individuals compared to those from unaffected family mem-
bers. This increase was strong at TD31 and was already detect-
able at TD11 (Figures 4G–4J). The increase in DLX1/2 andGAD1/
GAD67 was consistent in probands irrespectively of iPSC line, or
Figure 5. Sodium Currents in iPSC-Derived
Neurons from ASD Patients and Controls
Show Different Voltage Dependence of
Steady-State Inactivation
(A and B) Inward sodium currents evoked by
depolarizing test jumps to 20 mV from pre-test
potentials of 90 mV to 25 mV (A) or 45 mV
(B) in steps of 5 mV.
(C) Peak inward current amplitudes as a function
of pre-test potential from the data in (A and B). The
results were normalized to Imax values obtained
for each neuron from fits to the raw data (as in D
and E).
(D and E) Steady-state inactivation data obtained
from ten control neurons (D) and seven patient
neurons (E). Data for individual cells are shown
with different symbols and colors (normalized
data in (C) are shown here with the same
symbols: control, open black square; patient,
filled black circle). For some neurons, the results
were better fitted as the sum of two components
(arrowheads point to Eh1/2 values for each
component).
(F) Bar graph depicting the percentage of control
and patient neurons (n = 10 and 7) with Eh1/2
values that fell within the indicated ranges.
When two components were present, the frac-
tional amplitudes of each were used in the
calculation of mean percentages for each group.
Cells that gave Eh1/2 values % 65 mV gave
half-activation voltages that ranged from 39.1
to 55.8 mV, a phenotype most consistent with
the Nav1.1 brain sodium channel isoform (Cat-
terall et al., 2005).individuals within different families (Figures S4G–S4L). Also, the
increases in DLX1/2 and GAD1 in probands with respect to their
fathers were reproducible across independent differentiation
experiments (Figure S4M).
GABA precursors arose in a segregated fashion in an area of
the organoids and did not colocalize with TBR1+ excitatory
neuron precursors (Figure S5). The number of cells immunoreac-
tive for ASCL1/MASH1 and NKX2.1 (two TFs expressed by
GABAergic progenitor cells) and the neurotransmitter GABA
was also increased in ASD-derived organoids (Figure S5). More-
over, western blot analyses further confirmed increased protein
expression of GAD1/2 in ASD organoids (Figures S5Q and S5R).
Along with the upregulation of GSX2, ASCL1, DLX1, DLX2,
DLX5, DLX6, and DLX6-AS1, which is the top upregulated
gene at TD11 (Table S2) and the increase in GABA transporter
immunostaining (Figures 3H and 3I), these cellular analyses
strongly suggest an overproduction of progenitors and neurons
of the GABAergic lineage as well as an altered balance between
the number of excitatory and inhibitory neurons in organoids
derived from probands (Figure 4K).
We also found evidence for increased expression of
GABAergic phenotypes electrophysiologically. Although theCell 162, 375–size of sodium currents in control- and
proband-derived neurons was similar
(Figure S3), there was substantial cell-to-cell variation in the voltage dependence of activation and
inactivation, suggesting that different neurons express different
proportions of brain sodium channel isoforms (Nav1.1, Nav1.2,
Nav1.3, and Nav1.6). Figure 5 shows results for steady-state
inactivation. Neurons from probands and their familial controls
displayed substantial variation in the pre-test potential (Vpre) at
which the peak sodium current was reduced to half its maximal
amplitude (Eh1/2), and adequate fits to some of the data
required two Hodgkin-Huxley components (Figures 5D and
5E). Interestingly, sodium currents in proband-derived neurons
tended to inactivate at more hyperpolarized membrane poten-
tials than the corresponding currents in control neurons (Fig-
ure 5C–5E; n = 7 ASD and 10 control neurons). The increased
proportion of proband-derived neurons that gave Eh1/2 values
in the range 72 to 65 mV (Figure 5F) is consistent with
increased expression of the Nav1.1 isoform in these cells.
This isoform is preferentially expressed in GABAergic interneu-
rons (Cheah et al., 2012; Han et al., 2012; Ogiwara et al., 2007;
Yu et al., 2006) and the increased proportion of cells with this
sodium channel phenotype is consistent with a greater propor-
tion of GABAergic neurons in cortical organoids from probands
with ASD.390, July 16, 2015 ª2015 Elsevier Inc. 383
(legend on next page)
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FOXG1 Overexpression Causes Deregulated Cell
Differentiation in ASD Organoids
Our DGE results show that DLX6-AS1, TMEM132C, FOXG1,
C14orf23, and KLHDC8A are consistently among the top 10 up-
regulated genes at both TD11 and TD31 (Table S2A). Among
these genes, FOXG1, which is one of the top 100 hubs in the
magentamodule, with an 8.5- and 13-fold increase in expression
at TD11 and TD31, respectively (Table S2A), is a transcription
factor important for the development of the telencephalon (Ha-
nashima et al., 2004; Martynoga et al., 2005; Xuan et al., 1995).
Notably, loss-of-function mutations in FOXG1 have been found
in patients with atypical Rett syndrome (Ariani et al., 2008;
Bahi-Buisson et al., 2010; Shoichet et al., 2005) and confer a
small brain size (Kortu¨m et al., 2011). As the probands under
investigation have large brain size, it is possible that FOXG1
may be, at least in part, involved in the modulation of the brain
size phenotype and possibly in the social disability component
of the phenotype.
We therefore tested the hypothesis that abnormally high levels
of FOXG1 and its downstream genes could be responsible for
the phenotypic abnormalities identified in neuronal cells of
macrocephalic ASD patients. To this end, using lentiviruses car-
rying short hairpin RNAs (shRNAs) targeting FOXG1, we tested
whether an attenuation of the FOXG1 expression level in pa-
tients’ neural cells was able to revert some of the neurobiological
alterations.
As proof of principle, we generated four stable iPSCs lines
(three of which stably expressed different shRNAs specifically
targeting FOXG1 and one expressed a non-targeting shRNA
control) from a proband-derived iPSC line (07-P#9). To confirm
stable downregulation of FOXG1 expression, we performed
qPCR analyses at TD11 (Figure 6A). Introduction of two
FOXG1-targeting shRNAs (shRNA-2 and 3) downregulated
FOXG1mRNA expression to a level comparable to that of the un-
affected family member (Figure 6A, compare bar 6 and 7 with
bar 2). Immunostaining for FOXG1 confirmed that shRNA-2
and 3 were able to downregulate its expression also at the pro-
tein level (Figures 6B–6F). We next analyzed the expression of
GABAergic markers after FOXG1-RNA interference (RNAi) at
the transcript and protein level. At TD11, organoids derived
from the iPSC lines stably expressing FOXG1 shRNA-2 and
shRNA-3 (07-P#9 shRNA-2 and 3) showed downregulation of
DLX1, DLX2, and GAD1 transcripts as compared to the same
iPSC line expressing the shRNA control (07-P#9 shRNA-C) (Fig-
ures 6G–6I). Immunostaining and stereological quantification of
DLX1-2 and GAD1 positive cells showed that FOXG1 RNAiFigure 6. FOXG1 Knockdown in ASD-Derived Organoids Is Able to Res
(A) Relative expression levels of FOXG1 by qPCR among non-virally transduced
proband (07-P#9), his father (lines 07-F#1), and proband’s organoids harboring
FOXG1 (shRNA-1, shRNA-2, and shRNA-3).
(B–F) Double immunostaining for FOXG1 and PAX6 in TD11 non-transduced prob
(E), shRNA-3 (F).
(G–J), qPCR for DLX1 (G), DLX2 (H), GAD1 (I), and PAX6 (J) in TD11 organoids from
organoids derived from the father or the proband transduced with shRNA-C or s
(L and M) Stereological quantification of immunocytochemical (ICC) staining for
(L) and TD 31 (M). (Sample names: 07 = family name from which iPSCs were der
Data in (A, G–J, L, and M) are presented as means ± SEM; *p < 0.05, **p < 0.01,restored the normal level of GABAergic neuronal differentiation
in proband-derived organoids at both TD11 and TD31 (Figures
6K–6M). These results suggest that FOXG1 is involved, at
least in part, in causing the overproduction of neurons of the
GABAergic lineage found in ASD-derived organoids. FOXG1
RNAi had no or minor effects on the transcript/protein expres-
sion levels of dorsal forebrain markers (such as PAX6) (Figures
6 B–6F,6J, 6L, 6M), or on TFs directing cortical excitatory neuron
differentiation (such as TBR1) (Figure 6M).
To investigate the mechanism by which FOXG1 could affect
the overproduction of GABAergic neurons, we compared cell
proliferation in ASD- and control-derived organoids by BrdU
incorporation with or without FOXG1 RNAi. Quantification of
double-labeled BrdU+/Ki67+ cells at TD11 revealed no general
changes in proliferation between proband- and control-derived
organoids (Figures 7A and 7B and Figure S6A and S6B). How-
ever, there was a significant increase in the number of DLX2+
cells that incorporated BrdU in proband-derived organoids, as
well as an increased proportion of BrdU+ cells that colocalized
DLX1/2. Both effects were precluded by FOXG1-knockdown
(Figures 7A–7C). Furthermore, at TD31, proband-derived orga-
noids showed a greatly increased proportion of DLX+ and
GAD1+ cells that had incorporated BrdU at TD11 (Figures 7D–
7H), an effect that was also greatly attenuated by FOXG1
RNAi, which lowered the proportion of BrdU+/DLX+ and BrdU+/
GAD1+ cells in ASD-derived organoids to levels comparable to
those of the unaffected control (Figures 7D–7H). Moreover,
GAD1+ cells at TD31 were not aberrantly entering the cell cycle,
suggesting that GABAergic neurons were terminally differenti-
ated in the organoids (Figures S6C and S6D). Taken together,
these data suggest that the early increase in proliferation
of GABAergic neuronal progenitor cells in proband-derived orga-
noids gave rise to an increased proportion of mature GABAergic
interneurons, and that FOXG1 RNAi restored both these early
and late effects to levels comparable to those found in unaf-
fected family members. Similar experiments revealed smaller
or non-significant changes in the proliferation of PAX6+ and
TBR1+ precursor cells after FOXG1 RNAi (Figure S7), suggesting
that upregulated FOXG1 expression in ASD neural cells was
driving an early proliferative effect in neuronal precursor cells
of the GABAergic lineage.
FOXG1 Expression Correlates with Clinical Phenotype
Previous studies suggest a strong association between
increased head circumference (HC) in ASD and more severe
autism symptoms and lower IQ (Chaste et al., 2013; Chawarskatore the Balance between GABA/Glutamate Neuron Fate
undifferentiated iPSCs from proband #9 (i07-P#9), TD11 organoids from the
a non-targeting shRNA-control (shRNA-C) or three different shRNAs targeting
and’s organoids (B), or transduced with shRNA-C (C), shRNA-1 (D), shRNA-2
shRNA-C and shRNA-1/2/3. (K), DLX1-2 and GAD1 double immunostaining in
hRNA-3 at TD11 and TD 30.
GABAergic (DLX1-2, GAD1) and glutamatergic markers (PAX6, TBR1) at TD11
ived; F = Father; p = Proband; # = iPS clone number).
***p < 0.001, t test analysis. Scale bars, 10 mm.
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Figure 7. Increased Proportion of Proliferating GABAergic Neuronal Progenitors and Mature GABAergic Interneurons at TD31 in
ASD-Derived Organoids
(A–H) Representative images (A) and (D) and stereological quantification of BrdU+/DLX1-2+ proliferating cells (B), (C), (E), and (F) and BrdU+/GAD1+ neurons
(G) and (H) in TD11 and TD31 organoids derived from 07-F#2 (father), 07-P#9 shRNA-C, and 07-P#9 shRNA-3 (proband’s iPSC lines transduced with shRNA-C
or with shRNA-3). The selectively increased proportion of DLX 1-2+/BrdU+ double positive cells in patient-derived organoids at both TD11 (B) and (C) and TD31
(E) and (F), was restored to a physiological level after FOXG1-knockdown at both time points. The increased proportion of proliferating DLX1-2 GABAergic
progenitors (A and D, upper panel) resulted in an overproduction of more mature GABAergic GAD1+/BrdU+ double positive interneurons (D, bottom panel)
overproduction that was restored to physiological levels after FOXG1-knockdown (G and H).
Data in (B, C, E, F, G, and H) are presented as means ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001, t test analysis. Scale bars, 10 mm. See also Figures S6 and S7.et al., 2011; Lainhart et al., 2006). Given the small sample size
(n = 4) and limited range of severity scores in the probands, we
were not able to evaluate these associations directly. However,
in a supplementary analysis we obtained the correlations of inter-
est after adding five participants who did not all meet the strin-
gent criteria for macrocephaly that we required for deriving
iPSCs (see ‘‘Participant’’ section in Supplemental Experimental
Procedures) and thus display a wider spectrum of head circum-
ference sizes. Correlation analysis in this enriched sample (n = 9)
indicated strong associations between HC and autism symptom
severity (Spearman r = 0.79, p = 0.01) (data not shown).
Next, we correlated the patients’ HC and their autism symp-
tom severity with gene expression indices in our organoid
model in the four families used in this study. Despite the small
sample size, we found a consistent positive correlation between
HC and autism symptom severity with the upregulated modules
as well as a negative correlation with the downregulated mod-
ules (Figure 2D). The HC Z scores of probands displayed partic-
ularly strong correlations with all module’s eigengene and levels
of FOXG1 gene expression at TD31 (Figure 2D). However, the
module’s eigengenes displayed no correlation with the HC of386 Cell 162, 375–390, July 16, 2015 ª2015 Elsevier Inc.the unaffected fathers, despite the fathers presenting the
same degree of macrocephaly as the probands (see Figures
2E and 2F). Together, the observed patterns of correlations
suggest that the upregulation in the magenta, blue, brown,
and tan gene network is a maladaptive trait in the probands
and that it may represent a pathophysiological antecedent of
symptoms.
DISCUSSION
Our study provides a framework for studying normal human
brain development and its disorders. Using iPSC-derived
cortical organoids that recapitulate human first trimester telen-
cephalic development, we performed genome-wide transcrip-
tome analysis in four families affected by idiopathic ASD. The
affected individuals do not share any obvious underlying
genomic alterations, but all express a phenotypic trait that con-
fers increased symptom severity, macrocephaly. Despite the
heterogeneity in genotypes, we were able to identify perturba-
tions in coherent programs of gene expression and associated
features of altered neurodevelopment, namely upregulation of
cell proliferation, unbalanced inhibitory neuron differentiation,
and exuberant synaptic development.
The iPSC lines derived from ASD patients in these families
show decreased cell-cycle length, suggesting a generalized
increase in proliferative potential. These findings are in accord
with earlier hypotheses stating that abnormal control of cell
proliferation and overproduction of neurons might explain the
accelerated brain growth in ASD (Courchesne et al., 2011;
Courchesne et al., 2007; Vaccarino et al., 2009). However, the
increased proliferation is seen in early progenitors, but not at
later stages of cortical neural development in vitro, suggesting
powerful compensatory events that eventually restrict excessive
production of neurons in the cortical organoids and presumably
also in vivo.
In line with the transcriptome changes, we found biased pro-
duction of neuronal subtypes from cortical neuron precursors
of ASD probands, as compared with their fathers. Cortical orga-
noids of ASD probands show, at all time points analyzed,
exuberant GABAergic differentiation and no change in glutamate
neuron types, which together cause an imbalance in glutamate/
GABA neuron ratio. Interestingly, an unbiased stereological
study in post-mortem human samples showed an increase in
three GABA interneuron subtypes in various subregions of the
hippocampus in ASD, albeit in a small number of patients
(Lawrence et al., 2010). We also found that the overproduction
of GABAergic cells is attributable, at least in part, to an early in-
crease in FOXG1 gene expression, which drives an increased
proliferation and number of GABA precursor cells expressing
TF-driving GABAergic neuron fates, including the DLX homeo-
box genes (Rubenstein, 2010). FOXG1 inactivation in mice
causes premature lengthening of telencephalic progenitor cell
cycles and a failure to specify ventral (GABAergic) telencephalic
precursors, leading to a severely hypoplastic telencephalon
(Fasano et al., 2009; Martynoga et al., 2005). Hence, our data
in humans are consistent with the known roles of FOXG1 in
telencephalic growth as well as in the determination of GABA
neuron fate.
Notably, our genomic data do not support the presence of any
previously known deleterious mutation in any previously identi-
fied ASD candidate genes. Although we found no structural or
sequence DNA variation in the FOXG1 locus that could explain
the increase in FOXG1 gene expression (i.e., a duplication
involving the FOXG1 locus or a mutation in a TF binding site in
the proximal promoter region), it is possible that uncharacterized
SNVs in distal regions could affect FOXG1 expression. Future
research may uncover whether the gene expression dysregula-
tion that we identify in these patients with ASD is due to novel
mutations in genes that collectively affect the regulatory network
of FOXG1.
In addition to GABAergic neuron overproduction, we also find
evidence of exuberant cellular overgrowth of neurites and
synapses at the transcriptome and cellular levels and an in-
crease in GABAergic synapses, consistent with the increase
in GABAergic neuron number found in our preparation. This
increase is consistent with increased spine densities found in
the post-mortem cerebral cortex of ASD patients (Hutsler and
Zhang, 2010; Tang et al., 2014) as well as in the fmr1 KOmouse,
a model for fragile X syndrome, one of the most common formsof inherited intellectual disability and ASD (Do¨len et al., 2007).
Consistent with the cellular phenotype, mRNAs for the synaptic
adhesion molecules NLGN1, NRXN1, NRXN2, and NRXN3
were all overexpressed in patient-derived organoids. In contrast
to the present results, rare loss-of-function mutations in synaptic
adhesion molecules (SHANK, NLGN, NRXN) suggest a defi-
ciency in synaptic connections in some individuals with ASD.
However, a gain-of-function mutation in NLGN3 (R451C) found
in ASD confers an increase in GABAergic synaptic signaling
(Etherton et al., 2011; Pizzarelli and Cherubini, 2013; Tabuchi
et al., 2007). These apparently discrepant results may be recon-
ciled by the suggestion that the balance, rather than absolute
numbers, of glutamate and GABA neurons is important for func-
tion. Comparison of synaptic transmission and network activity
between patient and control organoids would further test this
hypothesis.
Thus, the early acceleration in the cell cycle, overproduction of
GABA neurons, and synaptic overgrowth may be antecedents of
the aberrant trajectory of cortical development found in children
with ASD. Neuropathological studies found an increased number
of neurons (Courchesne et al., 2011) and an increased number of
cortical minicolumns (Casanova et al., 2002) and synapses
(Hutsler and Zhang, 2010; Tang et al., 2014) in unselected cases
of ASD, suggesting increased production of cortical neurons. A
macroscopic increase in HC, found in 15%–20% of ASD cases,
confers a poorer outcome in ASD (Chaste et al., 2013; Chawar-
ska et al., 2011; Lainhart et al., 2006), suggesting that they repre-
sent the extreme of a continuum. Support for this hypothesis
comes from the finding that in our patient cohort there is a corre-
lation between the extent of change in gene expression in orga-
noids and degree of patient’s macrocephaly and symptom
severity. The finding that altered gene expression does not
correlate with HC in the unaffected fathers, despite the fathers
having the same degree of macrocephaly, suggests that the
macrocephaly in the fathers and in the probands are not equiva-
lent, and that additional genetic factorsmay control the head size
phenotype in ASD. Some studies also detected a different
pattern of brain enlargement between patients with ASD and
controls (Piven et al., 1996). Although the small number of partic-
ipants precludes a definitive conclusion, our data indicate that
the alterations in the dynamics of brain growth and differentiation
discovered using the organoid model represent a core feature of
the disorder, rather than an incidental finding, and that dysregu-
lated gene expression in iPSC-derived organoids, and FOXG1 in
particular, could be used as potential biomarkers of severe ASD.
Reinforcing the likely maladaptive function of altered levels of
FOXG1, deletions and missense mutations in this gene have
been associated with an atypical Rett syndrome and small brain
size (Ariani et al., 2008; Bahi-Buisson et al., 2010; Mencarelli
et al., 2010). This is interesting, as it suggests that deviations in
FOXG1 levels during brain development, in excess and defects,
cause opposite modulation in brain growth but a similarly
disabling outcome, characterized by intellectual disability and
ASD-like symptoms.
The results presented here suggest that a shared patho-
physiological mechanism might exist for idiopathic ASD. This
work implies that a number of common and rare causative ge-
netic risk factors can converge upon common mechanisms ofCell 162, 375–390, July 16, 2015 ª2015 Elsevier Inc. 387
pathogenesis. They also illustrate that directly studying neurode-
velopmental processes in patients with neuropsychiatric disor-
ders that have heterogeneous etiologies can open inroads into
diagnosis and therapy (Volkmar et al., 2009).
EXPERIMENTAL PROCEDURES
Induced Pluripotent Stem Cells
For each proband and first degree unaffected family members, iPSCwere pro-
duced using the classical retroviral approach or by a viral-free episomal re-
programming method (Okita et al., 2011). The iPSC lines from families 1123
and 03 have been previously described (Abyzov et al., 2012), and the iPSC
characterization for families 07 and 1120 is shown in Figure S1 and Figure S2.
Fibroblasts and iPSC lines have been submitted to the NIMH Center for
Collaborative Genomic Disorders on Mental Disorders (http://nimhgenetics.
org) at the Rutgers University Cell and DNA Repository (RUCDR).
Neuronal Differentiation
We differentiated iPSC lines into telencephalic neurons using a modification of
our free-floating tridimensional (3D) culture method (Mariani et al., 2012).
Briefly, floating aggregates composed of manually isolated neural rosettes,
which are early neural progenitors, were kept in suspension for 1 week under
growth-promoting conditions and then for 4 to 5weeks under conditions favor-
ing terminal differentiation (see Supplemental Experimental Procedures and
schematic outline in Figure S3A).
Electrophysiology
Conventional whole-cell patch-clamp recordings were made from individual
iPSC-derived neurons with an EPC9 amplifier and PatchMaster software
(HEKA). Preliminary experiments were conducted on dissociated monolayer
cultures and showed that voltage-activated currents were present as early
as 32 DIV and expression was stable out to 75 DIV. All subsequent character-
ization was performed on cells along the edges of the organoid preparations.
Voltage- and current-clamp protocols were generated by the software used for
data acquisition. Current and action potential amplitudes were measured in
PatchMaster. Curve fitting and additional analysis was performed after export-
ing the data to Igor (Wavemetrics).
Transcriptome Analysis by RNA-seq
Weanalyzed the transcriptome of 45 organoid samples, corresponding tomul-
tiple clones and three differentiation time points for four families, including a
father and a probands. Reads were aligned to the human hg19 reference
genome with Tophat (Trapnell et al., 2010). Gene expression levels were esti-
mated both as RPKM and counts using GencodeV7 gene annotation. RPKM
values were estimated by using RSEQTools (Habegger et al., 2011). Counts
were estimated by using BEDTools (Quinlan and Hall, 2010). After filtering
out low expression genes, we inferred differentially expressed genes by edgeR
(Robinson et al., 2010). Coexpressed gene modules were generated by
WGCNA (Langfelder and Horvath, 2008) using log2(RPKM+1) as input, after
filtering out low variance genes. DAVID (Dennis et al., 2003) and MSigDB
v4.0 (Subramanian et al., 2005) were used for overrepresentation in Gene
Ontologies and Canonical Pathways.
We compared the transcriptome of each of our 45 organoid samples to each
of the 524 RNA-seq sampels of developmental transcriptome of the human
brain from the BrainSpan Atlas (www.brainspan.org), to classify our samples
as corresponding to a particular brain region and developmental age. We com-
puted theSpearman correlationmatrix between the log transformedexpression
levels of our samples and each of the BrainSpan samples. Each iPSC-derived
neuronal sample was classified as corresponding to a particular brain sample
if its correlation coefficient was within the 95% confidence interval of the
maximum correlation coefficient. Average maximum correlation value is 0.86.
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